Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study.

@article{Demirel2013SaccharomycesBF,
  title={Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study.},
  author={Gamze Demirel and Omer Erdeve and Istemi Han Celik and Uğur Dilmen},
  journal={Acta paediatrica},
  year={2013},
  volume={102 12},
  pages={
          e560-5
        }
}
AIM To evaluate the efficacy of orally administered Saccharomyces boulardii (S. boulardii) for reducing the incidence and severity of necrotizing enterocolitis (NEC) in very low-birth-weight (VLBW) infants. METHODS A prospective, randomised controlled trial was conducted in infants with gestational age ≤32 weeks and birth weight ≤1500 g. The study group received S. boulardii supplementation, and the control group did not. The primary outcomes were death or NEC (Bell's stage ≥2), and secondary… CONTINUE READING
Highly Cited
This paper has 29 citations. REVIEW CITATIONS
Tweets
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 17 citations